The COVID-19 pandemic highlighted the urgent need for effective therapeutic agents against SARS-CoV-2. Although vaccines ...
Findings show potential for new lipid-based delivery formulations as a platform technology for immunizationPhiladelphia, PA, ...
Concurrent analysis of whole-genome DNA methylation and single-cell RNA sequencing data from COVID-19 patients and controls ...
Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...
Imagine a previously unknown bug—new to our immune defenses—that suddenly emerged and rapidly spread all over the globe, ...
Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into ...
AZoLifeSciences on MSN3d
New Insights into How B Cells Strategically Clone High-Affinity AntibodiesA vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a vaccine or pathogen, B cells scramble to refine their defenses, rapidly mutating ...
A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a vaccine or pathogen, B cells scramble to refine their defenses, rapidly mutating ...
A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a vaccine or pathogen, B cells ...
Successful high-affinity B cells can proliferate under special conditions that reduce the risk of mutation. Capturing this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback